Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Comparative study of OMNIgene®•SPUTUM reagent versus cold-chain for the transportation of sputum samples to GeneXpert®MTB/RIF testing sites in Malawi

 

Total n

Result

Age (yrs)

313

Median

42

Mean ± SD

42.3 ± 13.5

Range

2–79

Sex n (%)

312

Males

122 (39%)

Females

191 (61%)

Region of Malawi

313

Southern

169 (54%)

Central

85 (27%)

Northern

59 (19%)

HIV status n (%)

312

Pos

250 (80%)

Neg

31 (10%)

Unknown

31 (10%)

Prior TB diagnosis n (%)

313

Yes

21 (9%)

No

284 (91%)

Prior TB treatment n (%)

311

Yes

31 (10%)

No

280 (90%)

Collection type

 Spot sample n (%)

313

Yes

245 (78%)

No

68 (22%)

 Morning sample n (%)

312

Yes

74 (24%)

No

238 (76%)

 Both types collected n (%)

312

Yes

21 (7%)

No

291 (93%)

 Sputum character n (%)

305

Mucoid

130 (43%)

Purulent

28 (9%)

Mucopurulent

44 (14%)

Bloody

4 (1%)

Saliva

41 (13%)

Other

58 (19%)

 Transport/storage time (days)

304

Median

6

Mean ± SD

6.7 ± 5.0

Range

0–29

  1. HIV human immunodeficiency virus, TB tuberculosis. Results of interest agreement analysis of the use of utilizing Standard-of Care (SOC) Xpert had a positive agreement of 97% (κ = 0.97)